We have selected fructose transporter GLUT5 as a target due to its direct relevance to cancer, tightly regulated expression in normal cells, and our capability to specifically deliver small fluorescent molecular probes through this transporter into the cell [22]. The gene discussed is SLC2A5; the disease is cancer.